Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multiomic characterisation of the long-term sequelae of SARS survivors: a clinical observational study. | EClinicalMedicine | 2023 | 36873427 | PubTator, text mining | PubMed |
| Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing. | Genome Med | 2023 | 36869384 | PubTator, text mining | PubMed |
| Cancer-specific tissue-resident memory T-cells express ZNF683 in colorectal cancer. | Br J Cancer | 2023 | 36869093 | PubTator, text mining | PubMed |
| mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion. | Nat Commun | 2023 | 36869048 | PubTator, text mining | PubMed |
| Identification of key candidate genes and pathways in rheumatoid arthritis and osteoarthritis by integrated bioinformatical analysis. | Front Genet | 2023 | 36861127 | PubTator, text mining | PubMed |
| Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma. | Front Immunol | 2023 | 36860875 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis deciphers key transitional signatures associated with oncogenic evolution in human intramucosal oesophageal squamous cell carcinoma. | Clin Transl Med | 2023 | 36855810 | PubTator, text mining | PubMed |
| Bulk and single-cell characterisation of the immune heterogeneity of atherosclerosis identifies novel targets for immunotherapy. | BMC Biol | 2023 | 36855107 | PubTator, text mining | PubMed |
| S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review. | Vaccines (Basel) | 2023 | 36851081 | PubTator, text mining | PubMed |
| Phosphorylated signal transducer and activator of transcription proteins 1 in salivary glandular tissue: an important histological marker for diagnosis of primary Sjögren's syndrome. | RMD Open | 2023 | 36849206 | PubTator, text mining | PubMed |
| The immune-metabolic crosstalk between CD3+C1q+TAM and CD8+T cells associated with relapse-free survival in HCC. | Front Immunol | 2023 | 36845133 | PubTator, text mining | PubMed |
| Single-cell RNA-seq revealing the immune features of donor liver during liver transplantation. | Front Immunol | 2023 | 36845096 | PubTator, text mining | PubMed |
| Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis. | Front Immunol | 2023 | 36845083 | PubTator, text mining | PubMed |
| Insights into organoid-based modeling of COVID-19 pathology. | Virol J | 2023 | 36841795 | PubTator, text mining | PubMed |
| Transcriptional activation of Jun and Fos members of the AP-1 complex is a conserved signature of immune aging that contributes to inflammaging. | Aging Cell | 2023 | 36840360 | PubTator, text mining | PubMed |
| Salivary Metabolomic Analysis Reveals Amino Acid Metabolism Shift in SARS-CoV-2 Virus Activity and Post-Infection Condition. | Metabolites | 2023 | 36837882 | PubTator, text mining | PubMed |
| Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma. | Biomed Res Int | 2023 | 36825034 | PubTator, text mining | PubMed |
| Progress in salivary glands: Endocrine glands with immune functions. | Front Endocrinol (Lausanne) | 2023 | 36817607 | PubTator, text mining | PubMed |
| Prognostic and immunological role of sulfatide-related lncRNAs in hepatocellular carcinoma. | Front Oncol | 2023 | 36816914 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the immune microenvironment and signaling networks in cystitis glandularis. | Front Immunol | 2023 | 36814917 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=40